NCT04616235View on ClinicalTrials.gov

Acute Exercise and NK Cell Regulation in Tissue and Circulation After IL-6R Blockade

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 15, 2021

Primary Completion Date

October 4, 2021

Study Completion Date

October 4, 2021

Conditions
Interleukin-6 InhibitionPhysical StressAppetitive Behavior
Interventions
DRUG

Tocilizumab Injectable Product

The intervention group will undergo intense aerobic exercise with prior IL-6R infusion for 1h prior to the exercise bout.

OTHER

Saline 0.9% 100 ml NaCl 0.9% will be infused over 1 hour

The control group will undergo intense aerobic exercise with saline infusion for 1h prior to the exercise bout

Trial Locations (1)

2100

Center For Physical Activity (CFAS), Copenhagen Ø

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT04616235 - Acute Exercise and NK Cell Regulation in Tissue and Circulation After IL-6R Blockade | Biotech Hunter | Biotech Hunter